[Newsdesk] Typhoid conjugate vaccine gets WHO prequalification

On Jan 3, 2018, WHO announced the prequalification of a typhoid conjugate vaccine (TCV) manufactured by the Indian firm Bharat Biotech. The decision was expected after last year's endorsement by WHO's Strategic Advisory Group of Experts (SAGE) on immunisation, which recommended that the TCV be introduced for infants and children older than 6 months in typhoid-endemic countries.

Source: The Lancet Infectious Diseases - February 22, 2018 Category: Infectious Diseases Authors: Talha Burki Tags: Newsdesk Source Type: research